Cancer Research

[ Symptom Management Trials ]

Symptom management is care given to improve the quality of life of patients who have a serious or life-threatening disease. The goal of symptom management is to prevent or treat as early as possible the symptoms of a disease, side effects caused by treatment of a disease, and psychological, social, and spiritual problems related to a disease or its treatment. Also called comfort care, palliative care, and supportive care.

SWOG S1202: Aromatase Inhibitor Joint Pain in Women with Breast Cancer

The purpose of this study is to assess the effects, good and/or bad, of the medication duloxetine compared to placebo (contains no active ingredient) on your joint pain that is associated with taking aromatase inhibitors.  Duloxetine is a drug usually prescribed to treat depression or anxiety, pain caused by nerve damage or fibromyalgia (a painful muscle/bone/nerve disorder) and a muscle and bone pain from a type of arthritis.  Researchers on this study want to see if the pain relieving effects of the drug work for your type of pain. About 294 people will take part in this study.

SCUSF 0806: Protection of Heart Function in Patient Receiving Herceptin

The purpose of this study is to compare the effects, good and/or bad, of an ACE inhibitor (lisinopril) or a beta-blocker (Coreg CR® [carvedilol phosphate extended release]) on heart function during treatment with trastuzumab (Herceptin®), a drug you will receive as treatment for your breast cancer.  Lisinopril and Coreg CR® are used to treat high blood pressure, heart failure and in heart attack patients.  Study doctors want to find out which treatment (lisinopril or Coreg CR®) is better at protecting heart function during treatment of breast cancer.  The effect of the medicines will be compared to a placebo, which contains no active drug.  You will only get one of the study medicines (lisinopril, Coreg CR® or placebo). About 468people will take part in this study.

For further information, please call (510) 465-8573.